Transcriptomics,Genomics

Dataset Information

62

Expression data from CD8+TIM-3+ and CD8+TIM-3- T cells sorted from follicular lymphoma lymph nodes


ABSTRACT: Exhaustion markers are expressed by T lymphocytes in Follicular Lymphoma (FL). Through these, TIM-3 has been recently identified as a poor pronostic factor when expressed by FL CD4+ T cells. Before this study, there was no molecular characterization of unstimulated CD8+ T cells, expressing - or not - TIM-3. We used microarrays to compare the global gene expression profile between CD8+TIM-3+ T cells and CD8+TIM-3- T cells freshly sorted from follicular lymphoma biopsies. Abstract from the associated publication: Up-regulation of T-cell immunoglobulin-3 (TIM-3) has been associated with negative regulation of the immune response in chronic infection and cancer, including lymphoma. Here, we investigated the possible correlation between TIM-3 expression by ex vivo cytotoxic T cells (CTL) from follicular lymphoma (FL) biopsies and their functional unresponsiveness that could limit the favorable impact of CTL on disease progression. We report a high percentage of CD8+TIM-3+ T cells in lymph nodes of FL patients. When compared to their CD8+TIM-3- counterparts, CD8+TIM-3+ T cells exhibited defective cytokine production following TCR engagement. Furthermore CD8+TIM-3+ T cells display ex vivo markers of lytic granule release and remain unresponsive to further TCR-induced activation of the lytic machinery. Although confocal microscopy showed that TIM-3 expression on CD8+ T cells correlated with minor alterations of immunological synapse, a selective reduction of ERK signaling in CD8+TIM-3+ T cells was observed by phospho-flow analysis. Finally, short relapse free survival despite rituximab(R)-chemotherapy was observed in patients with high content of TIM-3+ cells and a poor infiltrate of granzyme B+ T cells in FL lymph nodes. Together, our data indicate that, besides selective TCR early signaling defects, TIM-3 expression correlates with unresponsiveness of ex vivo CD8+ T cells in FL. They show that scores based on the combination of exhaustion and cytolytic markers in FL microenvironment might be instrumental to identify patients at early risk of relapses following R-chemotherapy. Overall design: CD3+CD8+TIM-3+ and CD3+CD8+TIM-3- T cells from FL lymph nodes (n=3 patients) were sorted by flow cytometry and then the 6 samples were selected for RNA extraction and hybridization on GeneChip® Human Gene 2.0 ST microarrays.

INSTRUMENT(S): [HuGene-2_0-st] Affymetrix Human Gene 2.0 ST Array [probe set (exon) version]

SUBMITTER: Pauline Gravelle  

PROVIDER: GSE84072 | GEO | 2016-12-15

SECONDARY ACCESSION(S): PRJNA327936

REPOSITORIES: GEO

altmetric image

Publications


Upregulation of T cell immunoglobulin-3 (TIM-3) has been associated with negative regulation of the immune response in chronic infection and cancer, including lymphoma. Here, we investigated the possible correlation between TIM-3 expression by ex vivo cytotoxic T cells (CTL) from follicular lymphoma (FL) biopsies and their functional unresponsiveness that could limit the favorable impact of CTL on disease progression. We report a high percentage of CD8+TIM-3+T cells in lymph nodes of FL patients  ...[more]

Similar Datasets

| PRJNA327936 | ENA
2010-01-14 | E-GEOD-19882 | ArrayExpress
2013-11-12 | E-GEOD-48548 | ArrayExpress
2010-01-14 | GSE19882 | GEO
2011-09-26 | E-GEOD-14214 | ArrayExpress
2011-09-27 | GSE14214 | GEO
| GSE86613 | GEO
2013-07-16 | E-GEOD-40641 | ArrayExpress
2015-03-30 | E-GEOD-67385 | ArrayExpress
2016-01-14 | E-GEOD-76839 | ArrayExpress